Please login to the form below
Antibody Oligonucleotide Conjugates
This page shows the latest Antibody Oligonucleotide Conjugates news and features for those working in and with pharma, biotech and healthcare.
Lilly invests in antibody oligonucleotides conjugates with Avidity deal
Companies to develop new immonology medicines. Eli Lilly is aiming to develop new immunology drugs based on DNA/RNA molecules, and has enlisted the help of antibody oligonucleotide conjugates (AOC) specialist ... However a big obstacle in the class is
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Senior Account Manager
-
Competitive salary offered
-
CEO Pricing & Market Access, UK
-
Six figure salary
-
Omnichannel Strategy Consultant
-
Competitive Salary
-
CEO, Head of Health, UK
-
Six figure salary
- Valneva COVID-19 vaccine more effective than AZ
- Biosimilars boosted by FDA's landmark ruling for Boehringer’s Cyltezo
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Vertex moves ahead with its bid to develop a curative treatment for type 1 diabetes
- bluebird bio provides update on 2seventy bio spin-off
- Engaging HCPs on their own terms: how pharma can adapt to the post-pandemic digital era
- Live Webinar: Using Cybersecurity to Maintain Patient Data Integrity
- Merck’s COVID-19 antiviral under review in Europe by EMA
- AZ’s Imfinzi boosts survival in biliary tract cancer
- MAKING THE FIRST YEAR MATTER
- Merck receives first breast cancer approval in Europe for Keytruda
- Benefits of COVID-19 vaccine in younger children outweigh risks, says FDA
No results were found
PMHub
Syneos Health®
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...
Latest intelligence
- The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
- The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
- Mind the Gap – Challenging Immunisation Apathy and Misinformation
- world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
- Towards Better HCP Engagement – An Email Masterclass
- 6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....
